Latest updates for Bmrn

Fresh curated links around BMRN are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • BioMarin Pharmaceutical Inc. (BMRN) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
  • BioMarin Pharmaceutical
  • BioMarin Pharmaceutical

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

BioMarin Pharmaceutical Inc. (BMRN) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Read source
cafepharma.com /1 month ago

BioMarin Pharmaceutical

BioMarin Pharmaceutical Anonymous (not verified) Sat, 09/19/2026 - 21:55 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...

Read source
cafepharma.com /4 weeks ago

BioMarin Pharmaceutical

BioMarin Pharmaceutical Anonymous (not verified) Sat, 09/26/2026 - 00:59 field_thread_url https://cafepharma.com/boards/threads/biomarin-pharmaceutical.710...

Read source
seekingalpha.com /1 week ago

Nurix: Maintaining 'Strong Buy' Updated Bexobrutideg Data CLL/SLL And Multiple Advancement Pathways

Read source
seekingalpha.com /1 month ago

Scholar Rock jumps 12% after FDA approves isembyld for spinal muscular atrophy

Read source
seekingalpha.com /4 days ago

Trinity Capital commits $20M to respiratory care firm ABM

Read source
seekingalpha.com /1 month ago

Immuron Limited (IMRN) Presents at Coffee Microcaps Conference 2026 - Slideshow

Read source
orthospinenews.com /1 month ago

BioRestorative Therapies Announces Reverse Stock Split

MELVILLE, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (Nasdaq: BRTX) (“BioRestorative” or the “Company”), a late-stage clinical…

Read source
seekingalpha.com /1 month ago

Immuron reports FY results

Read source
cafepharma.com /1 month ago

BioXcel

BioXcel Anonymous (not verified) Sun, 08/30/2026 - 09:43 field_thread_url https://cafepharma.com/boards/threads/bioxcel.674502/ board na...

Read source
seekingalpha.com /1 month ago

BioXcel files for Chapter 11, will sell assets to Teva

Read source
seekingalpha.com /1 month ago

Neurocrine Biosciences, Inc. (NBIX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Read source
biopharmadive.com /1 month ago

Moonwalk reloads with $70M and new RNAi prospects for obesity

The California biotech plans to bring its first drug, enabled by licensing technology from a Chinese drugmaker, into clinical testing for obesity by the end of 2027.

Read source
seekingalpha.com /1 week ago

UroGen Pharma: An Emerging GARP Stock

Read source
seekingalpha.com /1 month ago

Bristol Myers Squibb's Breakout Is Here: Portfolio Renewal Gaining Momentum

Read source
seekingalpha.com /1 month ago

Opus Genetics, Inc. (IRD) Discusses Topline Results From Cohort 1 of BEST1 Phase I/II Gene Therapy Trial - Slideshow

Read source
seekingalpha.com /1 week ago

Biogen: The Bull Case Is Extending Beyond Alzheimer's (Rating Upgrade)

Read source
seekingalpha.com /1 month ago

BeOne Medicines AG (ONC) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Bmrn

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

orthospinenews.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

biopharmadive.com

Recent coverage from public sources
Public source